Pindolol antagonises G-protein activation at both pre- and postsynaptic serotonin 5-HT1A receptors: A [35S]GTPγS autoradiography study

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 363, Issue 4, 2001, Pages 391-398

  Newman Tancredi, A ^a   Chaput, C ^a   Touzard, M ^a   Millan, M J ^a  

^a INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

5 HT1A receptors; 35S GTP S; Autoradiography; Depression; G protein; Pindolol; SSRI

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; AUTORECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); PINDOLOL; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SULFUR 35;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN REGION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DENTATE GYRUS; DRUG EFFICACY; DRUG POTENTIATION; IC 50; NONHUMAN; POSTSYNAPTIC MEMBRANE; PRESYNAPTIC MEMBRANE; RAT; RECEPTOR BLOCKING;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; AUTORADIOGRAPHY; BINDING SITES; BRAIN; DRUG INTERACTIONS; GTP-BINDING PROTEINS; PINDOLOL; RATS; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS;

EID: 0035082816     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002100000306     Document Type: Article

References (67)

1. 1Dβ receptor
2. 1A receptor antagonists
3. 1B receptors
4. Current advances and trends in the treatment of depression
5. 1A receptors: Variations in intrinsic activity studied in transfected HeLa cells
6. Molecular biology of 5-HT receptors
7. Effect of pindolol on onset of action of paroxetine in the treatment of major depression: Intermediate analysis of a double-blind, placebo-controlled trial
8. Serotonin potentiates dopamine inhibition of ventral tegmental area neurons in vitro
9. Clinical and biochemical aspects of depressive disorders. II. Transmitter/receptor theories
10. 1A receptors in rat brain
11. 1A autoreceptor in vivo
12. 1A receptors in the rat brain
13. 1D autoreceptors
14. Stimulation and inhibition of adenylyl cyclase by distinct 5-hydroxytryptamine receptors
15. 1A receptor-stimulated responses in the human and monkey brain
16. 1A receptor to both adenylyl cyclase and phospholipase C is mediated via the same Gi protein
17. Pindolol, a putative 5-hydroxytryptamine1A antagonist, does not reverse the inhibition of serotonergic neuronal activity induced by fluoxetine in awake cats: Comparison to WAY100,635
18. Pindolol suppresses serotonergic neuronal activity and does not block the inhibition of serotonergic neurons produced by 8-hydroxy-2 (di-n-propylamino) tetralin in awake cats
19. Pindolol: A new β adrenoceptor antagonist with partial agonist activity
20. 1A autoreceptors
21. ia3
22. Effects of (-)-tertatolol, (-)-penbutolol and (±)-pindolol in combination with paroxetine on presynaptic 5-HT function: An in vivo microdialysis and electrophysiological study
23. 1B receptor inverse agonist 1′-methyl-5-[[2prime;-methyl-4′-(5-methyl-1,2,4-oxadiazol- 3-yl)biphenyl-4-yl]-2,3,6,7-tetrahydro-spiro[furo[2,3-f]indole-3,4′- piperidine] (SB-224289) potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo
24. 1B receptors
25. 1B receptors with WAY 100,635 and GR 127,935
26. Modulation of the firing activity of rat serotonin and noradrenaline neurons by (±)pindolol
27. 1A receptors
28. (-)-Pindolol, but not buspirone, potentiates the citalopram-induced rise in extracellular 5-hydroxytryptamine
29. B synaptic potential in rat dopamine neurones
30. 1A receptor antagonist
31. Immunocytochemi-cal localisation of serotonin1A receptors in the rat central nervous system
32. An electrophysiological comparison of pindolol-induced changes in dorsal raphe nucleus neuronal activity in vivo and in vitro
33. Comparative influence of (-)-pindolol upon the electrical activity of serotonergic, dopaminergic and adrenergic cell bodies in anaesthetised rats
34. Antidepressant-like behavioral effects of serotonin receptor agonists
35. Pindolol and mianserin augment the antidepressant activity of fluoxetine in hospitalized major depressed patients, including those with treatment resistance
36. Pindolol augmentation of antidepressant therapy
37. 11C-WAY100635
38. Effect of pindolol on hormone secretion and body temperature: Partial agonist effects
39. Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: A pharmacological characterization of the actions of novel agonists and antagonists
40. 1D receptors to G-protein coupling and function in corticolimbic structures
41. Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and adrenergic transmission in frontal cortex: A review, and relevance to the actions of antidepressant agents
42. 1A receptors as a function of receptor: G-protein stoichiometry
43. 1A receptors
44. 3H]S15535 autoradiography study
45. Involvement of beta-1 and beta-2 adrenergic receptors in the antidepressant-like effects of centrally administered isoprosterenol
46. Is the β-receptor down-regulation a prerequisite of the antidepressant activity?
47. 1A receptors that are negatively coupled to adenylate cyclase in permanently transfected Hela cells
48. 1A receptor agonists in recombinant cell lines. Modulation of apparent efficacy by G-protein activation state
49. Quantitative autoradiographic mapping of serotonin receptors in the rat. I. Serotonin receptors
50. Autoregulation of serotonin neurons: Role in antidepressant drug action
51. 1A receptors in the anticonflict activity of β-adrenoceptor antagonists
52. 11C]WAY100635 PET study
53. 1A receptor ligands to pre- and postsynaptic receptors by (-)pindolol. A comparative study in rodent, primate and human brain
54. 1A receptor: G protein coupling and signalling pathways
55. 1A receptors: In vivo microdialysis and electrophysiological studies in the rat brain
56. Cost-effectiveness of fluoxetine plus pindolol in patients with major depressive disorder: Results from a randomized, double-blind clinical trial
57. 1A receptor ligands by means of in vivo animal models
58. 1A receptor ligands in animal models of anxiety, impulsivity and depression: Multiple mechanisms of actions?
59. Pharmacological characterization of 8-OH-DPAT-induced inhibition of rat hippocampal 5-HT release in vivo as measured by microdialysis
60. 1B receptor antagonist on extracellular 5-HT in rat frontal cortex in vivo
61. Anxiolytic 5-hydroxytryptamine(1A) agonists suppress firing activity of dorsal hippocampus CA1 pyramidal neurons through a postsynaptic mechanism: Single-unit study in un-anesthetized, unrestrained rats
62. Paroxetine and pindolol: A randomized trial of serotonergic autoreceptor blockade in the reduction of antidepressant latency
63. A PHA-L analysis of ascending projections of the dorsal raphe nucleus in the rat
64. 35S]guanosine-5′-O-(3-thio)triphosphate binding to rodent brain sections as visualised by in vitro autoradiography
65. Stressor-induced anhedonia in the mesocorticolimbic system
66. How long should pindolol be associated with paroxetine to improve the antidepressant response?